Squamous differentiation is a potential biomarker predicting tumor progression in patients treated with pembrolizumab for urothelial carcinoma
Yu Miyama, Teppei Morikawa, Jimpei Miyakawa, Yuichi Koyama, Taketo Kawai, Haruki Kume, Tetsuo Ushiku
Topics & Concepts
PembrolizumabMedicineBiomarkerOncologyProgressive diseaseImmunohistochemistryCancerInternal medicineTumor progressionPathologyDiseasePathologicalImmunotherapyCancer researchBiologyBiochemistryBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersUrinary and Genital Oncology Studies